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Introduction 
Complementary and alternative medicine (CAM) refers to those practices, therapies and 
products not traditionally associated with the conventional medical community or the medical 
curriculum, such as acupuncture, naturopathy, and aromatherapy among others.1 CAM use is 
becoming increasing popular, especially amongst women.1, 2, 3 The rates of CAM use 
internationally vary considerably from 26% in England 4 to 76% in Japan 5. Within Australia 
the prevalence of CAM use has been reported to be 69%.6 One area of practice where CAM 
is making its presence felt is in pregnancy and birth.7   
 
CAM use in pregnancy 
The prevalence of CAM use in pregnancy has been commonly reported to range between 
20%-60%.8 The most popular CAM used by pregnant women include herbal medicine, 
vitamin and mineral supplements, relaxation therapies and aromatherapy.9, 10, 11 The 
popularity of CAM for pregnancy and birth may be representative of the fact that both health 
professionals and women are striving to regain control of their needs and health issues in the 
ever-increasingly medicalised sphere of maternity care.8, 12 Interestingly, it has been 
highlighted that pregnant women who use CAM are more likely to be using more than one 
therapy/modality interchangeably 13 and that such women will predominantly seek 
information regarding CAM from friends, family members and the internet, rather than from 
health professionals.8, 10  This demonstrates that a high proportion of women are often self-
prescribing rather than seeking professional guidance regarding CAM use in pregnancy.  
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 Issues related to self-prescribed CAM use  
Although the body of research focused on CAM is gradually evolving, the literature 
specifically related to the safety and trends of use within pregnancy is still lacking. Therefore, 
this raises concerns about the risks related to women’s self-prescribed use of CAM therapies 
within pregnancy in the absence of rigorous research.14 Here we define self-prescribed use of 
CAM as the use of complementary and alternative medicines or products purchased over-the-
counter from a health food store, pharmacy or supermarket without advice from a health care 
practitioner. Furlow et al, (2008) stated that 63% of pregnant women did not consult with 
their health professional before commencing use of CAM. The majority of women stated that 
they did not disclose their CAM use simply because they were never asked about it by their 
health professional.10 Alternatively, women may choose not to disclose their CAM use for 
fear of a negative response from their health professional.15 There are concerns regarding 
possible adverse reactions between medications/conventional treatments and CAM and so 
this emphasises the need for greater collaboration between women and their care providers to 
ensure women are using CAM safely during their pregnancy.2, 7  
 
Aromatherapy use within pregnancy 
Aromatherapy is the therapeutic use of highly concentrated essential oils and is a popular 
form of self-prescribed CAM used by pregnant women.9, 11 Evidence for the efficacy of 
aromatherapy during pregnancy, birth and postpartum is lacking with only two RCT studies 
included within a recent Cochrane Database Systematic Review.16 Both studies were 
underpowered resulting in a lack of statistical significance and external validity due to small 
sample sizes. However, it is important to note that there are a number of challenges to 
conducting RCTs of aromatherapy, such as: recruitment and randomisation can be 
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problematic because of participants’ beliefs and preferences; the identification of an 
appropriate placebo is often difficult or impossible, thus making the blinding of patients and 
researchers difficult; and there is little incentive for aromatherapists to do research, coupled 
with inadequate research infrastructure, and poor access to research funding.17, 18  
 
Moving beyond such RCT research, studies have reported aromatherapy use in labour as 
being beneficial. Burns et al (2000) found that the use of aromatherapy was rated as useful in 
labour by over 50% of the 8,058 mothers who participated.19 The study also found a 
significant 5.8% reduction in the use of pethidine for labour pain following the introduction 
of aromatherapy. 19 The findings of this study led to a large UK teaching hospital 
incorporating protocols for the use of aromatherapy within their maternity unit 20 and, further 
afield, aromatherapy is reportedly available within 76.6% of obstetric departments in 
Germany.21  
 
It has been suggested that women’s use of CAM, such as aromatherapy, may be motivated by 
a desire to avoid ingesting pharmaceutical medications during pregnancy, a position 
supported by women’s common perception that CAM is ‘natural’ and ‘free of side effects’ 
(while not being fully aware of any associated risks).9 Indeed, the use of volatile 
aromatherapy essential oils can be potentially unsafe in pregnancy and commentators have 
advised women to seek guidance from trained professionals (such as aromatherapists) rather 
than attempt self-administration.22 While it is important to acknowledge that toxicity is 
related to dose and therefore mode of delivery, jasmine, juniper, peppermint, clove, 
cedarwood, sage and rosemary are all examples of aromatherapy essential oils that should be 
avoided during pregnancy, with some of them possessing abortifacient properties.21 There are 
also essential oils such as clary sage, fennel and frankincense that should be restricted to use 
3 
 
in the third trimester due to their emmenagogic properties 23 and certain oils such as clary 
sage should only be used under professional guidance. 23  
 
The potential dangers of aromatherapy use by pregnant women highlights the significance of 
better understanding where and how pregnant women are obtaining information regarding 
their CAM use. Without access to quality information, pregnant women’s decision-making 
around the use of essential oils may be compromised, with serious implications for their 
pregnancy.  Health professionals’ lack of knowledge about CAM safety 2 and lack of 
awareness about where to refer women for guidance regarding these medicines has been 
considered by some to result in an increasing number of women self-administering CAM.24  
 
Examples of common pregnancy symptoms for which women use aromatherapy include 
nausea, headache, asthma, urinary tract infection, allergies/hayfever, anxiety and depression, 
haemorrhoids, insomnia, labour pain relief, oedema and for relaxation purposes.8, 25 For 
symptoms/ailments such as asthma, allergies and hayfever, pregnant women may choose 
CAM, such as aromatherapy, as an alternative to medicated forms of relief. Although many 
anti-histamine medications are viewed as relatively safe for use during pregnancy, many 
women may still be hesitant, especially given that  such symptoms may be endured 
throughout pregnancy and long-term use of anti-histamine use is not ideal.26 In relation to 
headache treatment in pregnancy, the safety of simple analgesics such as paracetamol, 
codeine and non-steroidal anti-inflammatory drugs (NSAID’s) such as ibuprofen is now 
debatable.27 There have been links between paracetamol use during pregnancy and an 
increased likelihood of childhood asthma 27, between use of NSAID’s and higher miscarriage 
rates and possible links between codeine use in pregnancy and increased risk of cleft palates 
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in infants.28 In view of such evidence, it is understandable that women may seek CAM, 
including aromatherapy, in an attempt to reduce any potential effects on fetal development.  
 
The use of aromatherapy by pregnant women has been largely under-researched and there has 
been no detailed empirical study of the prevalence and characteristics of such users 
undertaken in Australia to date. In response, this paper - reporting the first examination of the 
prevalence and characteristics of aromatherapy users amongst a large, nationally 
representative sample of pregnant Australian women - is a first step towards addressing this 






This research was conducted as part of the Australian Longitudinal Survey on Women’s 
Health (ALSWH) which was designed to investigate multiple factors affecting the health and 
well being of women over a 20-year period. Women in three age groups (“young” 18-23, 
“mid age” 45-50 and “older” 70-75 years) were randomly selected from the national Health 
Insurance Commission database. A total of 106,000 women in the three age groups were sent 
an invitation to participate and a questionnaire. Reminder letters, a nation-wide publicity 
campaign, information brochures, a freecall number for inquiries, and the option of 
completing the questionnaire by telephone in English or in the respondent's own language, 
were used to encourage participation. Response rates were 41% (n = 14,792), 54% (n = 
14,200) and 36% (n = 12,614) for the three age groups, respectively. The focus of the study 
reported here are women from the young cohort who have been surveyed five times over a 
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thirteen year period (1996-2009).29 The respondents to the baseline survey have been shown 
to be broadly representative of the national population of women in the target age group.30 
Wherever possible, previously validated questions or scales were included. Where 
appropriate instruments were not available or not suitable, the existing measures were 
modified or questions and scales were constructed and tested by the study investigators. 29 
The analyses reported here are restricted to the most recent survey (survey 5) of this young 
cohort, which was conducted in 2009 (when the women were aged 31-36 years). The 
ALSWH has ongoing ethical clearance from both the University of Newcastle and University 
of Queensland’s Human Research Ethics Committees. 
 
Measures of demographic characteristics 
Postcode of residence was used to classify area of residence as urban or non-urban. Women 
were asked about their current marital status and the highest educational qualification 
completed. 
 
Measure of health status 
Women were asked to indicate if they were currently pregnant. In terms of illness, women 
were asked how often they experienced a list of common symptoms in the previous twelve 
months. This list included: allergies/hay fever, headaches/ migraines, back pain, stiff/painful 
joints, vaginal discharge or irritation, severe tiredness, urine that burns or stings, leaking 
urine, haemorrhoids, and sleeping problems. Women were also asked whether a doctor had 
ever told them that they had any medical conditions from a list provided which included: 
asthma, low iron (iron deficiency or anaemia), hypertension, depression, anxiety disorder, and 




Health service utilisation 
The women were asked about their frequency of consultations in the previous twelve months 
with a general practitioner (GP) and a specialist doctor. In addition, they were asked if they 
had consulted with a midwife, massage therapist, acupuncturist, naturopath/herbalist, 
chiropractor/osteopath, other alternative health practitioner (eg. aromatherapist, homeopath, 
reflexologist, iridologist) in the previous twelve months. 
 
Use of aromatherapy oils 
Women were asked how often (ie. never, rarely, sometimes, often) they had self-prescribed 
the use of aromatherapy oils, for their own health, in the previous twelve months. Women 
who indicated that they used aromatherapy oils either “sometimes” or “often” were 
considered to be users of aromatherapy oils. 
 
Statistical analyses 
Chi-square tests were used to examine bivariate associations. Multiple logistic regression 
modelling was employed to determine the statistically significant factors associated with 
aromatherapy oils use. All the demographic, symptoms and diagnoses variables listed above 
were entered into a model and then a stepwise backward elimination process was employed, 




In 2009 (survey 5) there were 8,200 women of which 804 (9.8%) were pregnant at the time of 
the survey. Of the pregnant women, 62.2% resided in an urban area, 98.4% were in a married 
or defacto relationship, and 62.4% had a university education.  
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 Self-prescribed aromatherapy oils were used by 15.2% of pregnant women and 17.5% of 
non-pregnant women, which was not significantly different (p=0.101). Table 1 shows the 
associations between consultations with health care practitioners and self-prescribed use of 
aromatherapy oils, by pregnant and non-pregnant women. In comparison to pregnant women 
who did not use aromatherapy oils, pregnant women who used aromatherapy oils were less 
likely to consult with a specialist three or more times (p=0.004), but more likely to consult 
with a massage therapist (p=0.001), naturopath/herbalist (p<0.001), or other alternative 
practitioner (p=0.035). For non-pregnant women, those who self-prescribed use of 
aromatherapy oils were more likely to consult with all CAM practitioners (all p<0.001) and 
GPs (p=0.001), compared with non-pregnant women who did not use aromatherapy oils.  
 
In comparison to pregnant women who did not use aromatherapy oils, those who self-
prescribed use of aromatherapy oils were more likely to have experienced allergies/hayfever 
(p=0.039),  headaches/migraines (p=0.031), and UTIs (p=0.003). A similar association was 
also found between self-prescribed aromatherapy oil use and these three symptoms for non-
pregnant women. Further, for non-pregnant women, self-prescribed use of aromatherapy oils 
was significantly higher for women who had experienced back pain, stiff/painful joints, sleep 
problems, vaginal discharge, severe tiredness, low iron levels, depression, and anxiety. 
 
The logistic regression modelling resulted in only two symptoms (out of all the symptoms 
and diagnoses) being deemed statistically significant predictors of self-prescribed use of 
aromatherapy oils by pregnant women, these being allergies/hayfever and UTI (data not 
shown). Specifically, the odds of a pregnant women self-prescribing use of aromatherapy oils 
is: 1.57 (95% CI: 1.01, 2.43) times greater if they have allergies/hayfever, compared to 
8 
 
women without allergies/hayfever; and 2.26 (95% CI: 1.34, 3.79) times greater if they have a 




This study represents the first examination of pregnant women’s self-prescribed use of 
aromatherapy oils based on analyses of a large, nationally representative sample of Australian 
women. The study presents three key findings. The study reveals that aromatherapy oils were 
used by a considerable proportion of pregnant women, a finding supported by previous work 
by Skouteris et al (2008) who reported a similar prevalence of aromatherapy oils use by 
pregnant women in Australia.  This is a significant finding, especially given that the 
prevalence of aromatherapy oils use by pregnant women is similar to that of non-pregnant 
women, and appears to suggest that pregnant women are not reducing or forgoing their use of 
aromatherapy oils and as such may be unaware of the potential risks of aromatherapy oil use 
during pregnancy. This is of greater concern when aromatherapy oil use is self-prescribed. 
 
Our analyses also identified associations between pregnant women’s use of aromatherapy oils 
and their consultations with various providers. Pregnant women who consult with a massage 
therapist or naturopath/herbalist are more likely to use aromatherapy oils. This is perhaps 
unsurprising given that massage therapists and naturopaths often use essential oils in their 
own practice.31, 32 Nevertheless, further research is needed to determine the level of education 
such CAM therapists receive in training regarding the safe use of aromatherapy oils by 
pregnant women. Conversely, pregnant women are less likely to use aromatherapy oils if they 
have consulted a specialist. Given that obstetricians consider aromatherapy oils use to be of 
no benefit for pregnant women,9  this finding may reflect obstetricians’ discouragement of 
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aromatherapy oils use, or alternatively, obstetricians may be cautious in recommending the 
use of CAM to their patients due to the current limited educational opportunities for 
undergraduate and postgraduate training in the area of CAM. 9 There was no significant 
relationship between self-prescribed use of aromatherapy oils by pregnant women and 
consultation with a midwife. This is an interesting finding in light of the review by Hall et al. 
(2012) which reported that most midwives perceived their education in CAM to be 
inadequate.  
 
Finally, it appears from our analyses that aromatherapy oils are used by a substantial number 
of pregnant women to treat allergies/hayfever and/or UTI. In these cases, it is possible that 
the aromatherapy oils use may be an attempt by these women to avoid using pharmaceutical 
options such as antihistamines or antibiotics, due to concerns over potential harm to their 
unborn child. 9 Further, UTI is a known risk factor for preterm birth and small-for-
gestational-age babies 33 and this raises concern if aromatherapy oils are used but are 
ineffective in treating UTI. Further research is required to determine the specific 
aromatherapy oils used by pregnant women and to examine the concerns of pregnant women 
regarding the potential harm of conventional treatments for allergies and UTI. 
 
The interpretation of our findings is potentially limited by the fact that the data analysed is 
self-reported by the participants and so our results may be open to the effects of recall bias. In 
addition, the medical conditions and symptoms were defined by self-report and the lack of 
confirmatory diagnosis could potentially bias findings. The main strengths of this study are 






Our study highlights a considerable use of aromatherapy oils by pregnant women. Regardless 
of the reasons why pregnant women choose to use aromatherapy oils, there is a clear need for 
greater communication between practitioners and pregnant women regarding the use of 
aromatherapy oils as well a need to educate health care practitioners that pregnant women in 
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Table 1   The associations between consultations with health care practitioners and self-prescribed 
use of aromatherapy oils, by pregnant and non-pregnant women. 
  Pregnant  Non-Pregnant  
Health Care  Used Aromatherapy Oils  Used Aromatherapy Oils  
Practitioners  No Yes p-value No Yes p-value 
  (n=682) (n=122)  (n=6098) (n=1298)  
  % %  % %  
GP  0 1 0 0.064 6 5 0.001 
consultations 1-2 26 18  36 31  
 3+ 73 82  58 64  
Specialist 0 30 28 0.004 54 51 0.149 
consultations 1-2 24 37  24 26  
 3+ 46 35  22 23  
Midwife yes 49 50 0.735    
 no 51 50     
Massage yes 38 55 0.001 37 57 <0.001 
 no 62 45  63 43  
Acupuncture yes 11 12 0.566 7 15 <0.001 
 no 89 88  93 85  
Naturopath / yes 12 24 <0.001 9 25 <0.001 
herbalist no 88 76  91 75  
Chiropractor / yes 22 26 0.357 23 31 <0.001 
osteopath no 78 74  77 69  
Other  yes 6 11 0.035 6 19 <0.001 
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Alternative no 94 89  94 81  
 
Table 2   The associations between common symptoms and diagnosed conditions and self-
prescribed use of aromatherapy oils, by pregnant and non-pregnant women. 
  Pregnant  Non-Pregnant  
Symptoms and 
Diagnoses 
Used Aromatherapy Oils  Used Aromatherapy Oils  
No Yes p-value No Yes p-value 
  (n=682) (n=122)  (n=6098) (n=1298)  
  % %  % %  
Allergy / yes 36 46 0.039 42 47 0.005 
hayfever no 64 54  58 53  
Headaches /  yes 40 50 0.031 53 59 <0.001 
migraines no 60 50  47 41  
Back pain yes 38 38 0.939 44 51 <0.001 
 no 62 62  56 49  
Stiff/painful yes 15 16 0.890 24 30 <0.001 
joints no 85 84  76 70  
Sleep  yes 27 26 0.725 34 45 <0.001 
problems no 73 74  66 55  
Severe  yes 48 47 0.983 48 55 <0.001 
tiredness no 52 53  52 45  
Vaginal yes 13 7 0.060 13 15 0.048 
discharge no 87 93  87 85  
Urine burns/ yes 5 4 0.805 5 6 0.093 
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stings no 95 96  95 94  
Urine leaking yes 13 9 0.267 11 11 0.909 
 no 87 91  89 89  
UTI yes 13 25 0.003 14 18 0.002 
 no 87 75  86 82  
Haemorrhoids yes 12 10 0.513 11 12 0.695 
 no 88 90  89 88  
Low iron yes 17 19 0.657 17 22 <0.001 
levels no 83 81  83 78  
Depression yes 11 15 0.218 17 23 <0.001 
 no 89 85  83 77  
Anxiety yes 5 8 0.181 10 15 <0.001 
 no 95 92  90 85  
Asthma yes 10 12 0.537 10 11 0.391 
 no 90 88  90 89  
Hypertension yes 3 2 0.467 5 5 0.427 
 no 97 98  95 95  
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